Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion type Assertion NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_head.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_provenance.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion evidence source_evidence_literature NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_provenance.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion SIO_000772 21983935 NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_provenance.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion wasDerivedFrom befree-20150227 NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_provenance.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion wasGeneratedBy ECO_0000203 NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_provenance.